Arpelos Biosciences
PrivateLast Round
Seed
Mar 15, 2024
Total Funding Raised
$9.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arpelos Biosciences is a biotechnology company that develops multivalent medicines to achieve unprecedented potency and selectivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arpelos Biosciences Comparables
Compare Arpelos Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthetic Design Lab | 84% | |
| Valink Therapeutics | 82% | |
| AI Proteins | 76% |
Arpelos Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 15, 2024 |
Arpelos Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lux Capital | Seed |
| General Catalyst | Seed |
| Pillar VC | Seed |
| 82VS | Seed |
| Wing Venture Capital | Seed |
| 8VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 32% MoM.
- Jun 18, 2026
Monthly visitors grew 42% MoM.
Arpelos Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arpelos Biosciences's valuation, stock price, and market status.
Is Arpelos Biosciences a public or private company?
Arpelos Biosciences is a private company.
What is the current stock price of Arpelos Biosciences?
Arpelos Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Arpelos Biosciences worth (valuation)?
Valuation information for Arpelos Biosciences is not publicly available.
Can I buy Arpelos Biosciences stock?
Arpelos Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arpelos Biosciences's last funding round?
Arpelos Biosciences's most recent funding round was Seed on March 15, 2024.
Who are the main investors in Arpelos Biosciences?
Key investors in Arpelos Biosciences include Lux Capital, General Catalyst, Pillar VC, 82VS, Wing Venture Capital.
Will Arpelos Biosciences IPO soon?
No public IPO plans have been announced for Arpelos Biosciences.
How can I track Arpelos Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arpelos Biosciences's secondary market activity and sign up for updates.